InsiderTrades

Form 4 for BVS Bioventus Inc.

Accepted 2023-06-08 00:00:00 ET · period of report 2023-06-06 · accession 0001578563-23-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-08 2023-06-06 BVS Bartholdson John A. Dir M - OptEx $0.00 +7,576 7,576 New $0
D 2023-06-08 2023-06-07 BVS Bartholdson John A. Dir A - Grant $0.00 +30.4K 30.4K New $0
D 2023-06-08 2023-06-06 BVS Bartholdson John A. Dir M - OptEx $0.00 -7,576 15.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-06-06 M A 7,576 $0.00 7,576 D — —
2 Derivative Restricted Stock Units 2023-06-07 A A 30,400 $0.00 30,400 D — · — to — 30,400 Class A Common Stock (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F5) The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
3 Derivative Restricted Stock Units 2023-06-06 M D 7,576 $0.00 15,151 D — · — to — 7,576 Class A Common Stock (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F4) 7,576 RSUs vested on June 6, 2023. The remaining 15,151 RSUs shall vest and become exercisable in two approximately equal installments on June 6, 2024 and June 6, 2025, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.